Research and Markets: The Neurodevice 2013 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware

Fri Aug 9, 2013 11:51am EDT

* Reuters is not responsible for the content in this press release.

Research and Markets: The Neurodevice 2013 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware

Research and Markets (http://www.researchandmarkets.com/research/w9xv6z/the_neurodevice) has announced the addition of NeuroInsights's new report "The Neurodevice 2013 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware" to their offering.

An Industry Insider Report Covering Therapeutic Neurodevices including Neuroprosthetics, Neuromodulation, Neurovascular Interventions, Neurosurgical Devices and Neurosoftware

Nearly 2 billion people worldwide and 100 million people in the US are affected by a brain or nervous system disorder including addiction, Alzheimer's, depression, anxiety, schizophrenia, attention disorders, epilepsy, Parkinson's disease, sensory disorders, stroke, traumatic brain injury, obesity, sensory disorders and sleep disorders. Therapeutic devices are stepping in where pharmaceuticals have failed to provide solutions. Venture and corporate investors have provided over $3 billion in investment to private neurodevice companies over the past seven years. These investments have sometimes produced lucrative exits and sometimes utter failures. Find out about the next wave of neurodevices in development, the competitive landscape, the market opportunities and the return on investment potential in 150 page The Neurodevice 2013 Report.

Key Topics Covered:

1 Neurodevice Sector Overview

  • Neurodevice Markets and Revenues
  • Neurodevice Sector Trends
  • Regulatory Process in the US
  • Regulatory Process in the EU
  • Medical Device Giants Shape Neurodevice Market
  • Investments by Major Medical Device Players (2005-Q22013)
  • Neurodevice Company Merger and Acquisition Activity (2005-Q22013)

2 Neuroprosthetic Devices

  • Cochlear Implants
  • Retinal Implants
  • Motor Prostheses and Brain Computer Interfaces

3 Neuromodulation Devices

  • Neuromodulation Device Clinical Trials and Recent Approvals
  • Deep Brain Stimulation (DBS)
  • Transcranial Magnetic Stimulation (TMS)
  • Transcranial Electrical Stimulation (TES)
  • Focused UltraSound Modulation
  • Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Peripheral Stimulation
  • Gastric Modulation and Obesity

4 Neurosurgical devices

  • Radiosurgical and Precision Laser Devices
  • Neurosurgical Navigation and Equipment
  • Neurovascular Intervention

5 Neurosoftware

  • Attention Deficit Disorder and Learning Disabilities
  • Autism
  • Cognition and Aging
  • Stress and Emotional Wellbeing
  • Addiction and Obesity
  • Pain
  • Schizophrenia
  • Traumatic Brain Injury and Concussion

6 Company Interviews

  • BeneChill
  • Brain Resource Spins out MyBrainSolutions
  • Click Therapeutics
  • Blue Marble Game Company
  • EnteroMedics
  • Functional Neuromodulation
  • Hermo Pharma
  • ImThera Medical
  • Microtransponder
  • Neuronix Medical
  • NeuroSigma
  • Nexstim
  • Spinal Modulation
  • StimWave Technologies

7 Company Profiles

  • Neurodevice Companies: Private
  • Neurodevice Companies: Public

8 Index

For more information visit http://www.researchandmarkets.com/research/w9xv6z/the_neurodevice

Source: NeuroInsights

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Central Nervous System